Patents Assigned to CANANDIAN BLOOD SERVICES
  • Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System
    Publication number: 20170173078
    Abstract: This disclosure relates to a cellular-based therapies for modulating the level of regulatory T cells (Treg) and/or the level of pro-inflammatory T cells (Th17/Th1). To provide these therapeutic effects, a combination comprising at least one a cellular pro-tolerogenic preparation and at least one a cellular pro-inflammatory preparation are administered sequentially.
    Type: Application
    Filed: July 10, 2015
    Publication date: June 22, 2017
    Applicant: CANANDIAN BLOOD SERVICES
    Inventors: Mark D. Scott, Duncheng Wang, Wendy M. Toyofuku